U.S. market Closed. Opens in 12 hours 4 minutes

AMRX | Amneal Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312018-12-312017-12-312016-12-31
Revenue2.39B2.39B2.21B2.21B2.09B2.09B1.99B1.99B1.63B1.63B1.66B1.03B1.02B
Cost of Revenue1.57B1.54B1.43B1.43B1.32B1.32B1.36B1.36B1.27B1.27B946.59M507.48M420.77M
Gross Profit820.57M846.13M784.71M784.71M768.97M768.97M628.39M628.39M353.00M353.00M716.40M526.18M597.46M
Operating Expenses596.32M584.71M595.79M595.79M575.07M575.07M517.31M517.31M491.88M491.88M440.89M300.98M323.50M
Selling, General & Admin429.68M422.83M399.70M399.70M365.50M365.50M326.73M326.73M289.60M289.60M230.44M109.05M118.76M
Research & Development167.78M164.48M200.05M200.05M209.56M209.56M190.59M190.59M202.29M202.29M210.45M191.94M204.75M
Other Operating Expenses5.12M7.77M-3.96M-3.96M15.33M15.33M2.59M2.59M1.47M1.47M2.85MN/AN/A
Operating Income204.37M226.21M206.46M206.46M209.24M209.24M91.16M91.16M-137.42M-137.42M-19.67M245.10M273.95M
Other Expenses / Income-13.09M-27.48M-454.59M-454.59M-177.87M-177.87M-126.94M-126.94M-82.82M-82.82M-334.67M-73.78M-59.13M
Before Tax Income-40.27M35.54M-248.13M-248.13M31.37M31.37M-35.78M-35.78M-220.24M-220.24M-202.72M171.32M214.82M
Income Tax Expenses8.45M-3.23M6.66M6.66M11.20M11.20M-104.36M-104.36M383.33M383.33M-1.42M2.00M5.39M
Net Income-83.99M10.32M-254.79M-254.79M20.17M20.17M68.58M68.58M-603.57M-603.57M-169.73M167.65M207.38M
Interest Expenses210.63M198.11M158.38M158.38M136.32M136.32M146.00M146.00M168.21M168.21M143.57M71.06M55.28M
Basic Shares Outstanding176.14MN/A150.94M150.94M148.92M148.92M147.44M147.44M132.11M132.09M127.25M114.86M114.86M
Diluted Shares Outstanding176.14MN/A150.94M150.94M151.82M151.82M148.91M148.91M132.11M132.11M127.25M114.86M114.86M
EBITDA417.96M502.42M446.64M446.64M442.64M442.64M349.06M349.06M69.81M69.81M415.77M286.64M301.07M
EBITDA Margin17.46%21.05%20.19%20.19%21.14%21.14%17.52%17.52%4.29%4.29%25.00%27.73%29.57%
EBIT135.09M205.20M-89.75M-89.75M167.69M167.69M110.22M110.22M-52.04M-52.04M-27.57M240.71M268.06M
EBIT Margin5.64%8.60%-4.06%-4.06%8.01%8.01%5.53%5.53%-3.20%-3.20%-1.66%23.29%26.33%
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙